L. Zhu

发表

Rare synchronous primary large B-cell gastric lymphoma and huge retroperitoneal liposarcoma with inguinal hernia in chronic hepatitis B patient.

Prasanna Ghimire, G. Wu, L. Zhu, 2011, Current oncology.

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17.

P. Gibbs, N. Pavlakis, J. Meharchand, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

The impact of medical visits for chemotherapy-induced anemia and neutropenia on the patient and caregiver: a national survey

L. Schwartzberg, B. Fortner, K. Tauer, 2004 .

Costs of human resources in delivering cancer chemotherapy and managing chemotherapy-induced neutropenia in community practice

T. Okon, L. Schwartzberg, K. Moore, 2004 .

The influence of hypomagnesemia (hMg) on overall survival (OS) in a phase III randomized study of cetuximab (CET) plus best supportive care (BSC) versus BSC: NCIC CTG/AGITG CO.17.

P. Gibbs, N. Pavlakis, J. Meharchand, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nanoscale extracellular vesicle-derived DNA is superior to circulating cell-free DNA for mutation detection in early-stage non-small-cell lung cancer

Y. Wan, B. Liu, L. Zhu, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[Clinical application of STR genotyping diagnosis for hydatidiform mole and nonmolar gestation].

J. H. Ma, X. Z. Zheng, X. Wang, 2018, Zhonghua bing li xue za zhi = Chinese journal of pathology.

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial

K. Davison, V. Kukreti, M. Crump, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Subcutaneous bronchogenic cyst in the scapular region presenting as an acute abscess

R. Kimble, L. Zhu, J. Davies, 2014 .

Inflammatory Myofibroblastic Tumor of Lung - Computed Tomographic Features in 20 Patients

Prasanna Ghimire, G. Wu, L. Zhu, 2012 .

A phase III study of cetuximab (CET) plus either brivanib alaninate (BRIV) versus placebo in patients with chemotherapy-refractory KRAS wild-type (WT) advanced colorectal cancer (aCRC): The NCIC CTG/AGITG CO.20 trial.

D. Tu, M. Moore, J. Zalcberg, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)--results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care.

P. Gibbs, N. Pavlakis, D. Tu, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Consequences of additional use of contrast-enhanced 18F-FDG PET/CT in target volume delineation and dose distribution for pancreatic cancer

Wengui Xu, L. Zhu, P. Ren, 2015, The British journal of radiology.

The new language of cancer care: contribution to working capital, human resource costs, practice efficiency, and opportunity costs

T. Okon, B. Fortner, L. Zhu, 2005 .

A phase 2, randomized study of nivolumab or nivolumab plus BMS-986205 with or without intravesical bacillus Calmette-Guerin in patients with bacillus Calmette-Guerin–unresponsive, high-risk, non-muscle invasive bladder cancer: CheckMate 9UT

M. Meng, Sam S. Chang, J. Witjes, 2019, European Urology Supplements.

Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients

A. Leo, M. Toi, L. Biganzoli, 2017, Asia-Pacific journal of clinical oncology.

P1.03-019 Sophoridine Inhibits Lung Cancer Cell Proliferation through Activating Hippo Signaling and P53 Pathway

S. Huang, L. Zhu, J. Xiong, 2017 .

518MO Tolerability and preliminary clinical activity of SY-5609, a highly potent and selective oral CDK7 inhibitor, in patients with advanced solid tumors

G. Shapiro, D. Juric, G. Hodgson, 2021, Annals of Oncology.

KEYNOTE-151: A phase Ib study of second-line pembrolizumab (Pembro) for Chinese patients (pts) with advanced or metastatic melanoma.

H. Pan, Y. Zhou, Y. Shu, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.